Clinical Trial Update: Cardiac Biomarker in Pediatric Heart Disease

View source ↗

Summary

A completed clinical trial from Okayama University evaluating a cardiac biomarker in pediatric congenital heart disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Disease

Snippet

Sponsor: Okayama University | Conditions: Congenital Heart Disease | Status: COMPLETED